STOCK TITAN
  1. Home
  2. News
  3. AMGN
  4. BetterInvesting™ Magazine Update on Stride Inc. (NYSE: LRN) and Amgen Inc. (NASDAQ: AMGN)

BetterInvesting™ Magazine Update on Stride Inc. (NYSE: LRN) and Amgen Inc. (NASDAQ: AMGN)

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
BetterInvesting Magazine's Editorial Advisory and Securities Review Committee has selected Stride Inc. (NYSE:LRN) as its "Stock to Study" for the August 2025 issue, suggesting potential investment opportunities. The committee will provide a comprehensive analysis of Stride's fundamental data, including sales, earnings, pre-tax profit, and return on equity. Additionally, the magazine will feature a fundamental review of Amgen Inc. (NASDAQ:AMGN), which the committee considers worthy of study from an undervalued perspective. The committee comprises six CFA professionals, with Doron P. Levin serving as chairperson.
Il Comitato Editoriale e di Revisione dei Titoli della rivista BetterInvesting ha selezionato Stride Inc. (NYSE:LRN) come "Azione da Studiare" per il numero di agosto 2025, suggerendo potenziali opportunità di investimento. Il comitato fornirà un'analisi completa dei dati fondamentali di Stride, inclusi vendite, utili, profitto ante imposte e rendimento del capitale proprio. Inoltre, la rivista presenterà una revisione fondamentale di Amgen Inc. (NASDAQ:AMGN), che il comitato ritiene meritevole di studio da una prospettiva di sottovalutazione. Il comitato è composto da sei professionisti CFA, con Doron P. Levin in qualità di presidente.
El Comité Editorial y de Revisión de Valores de la revista BetterInvesting ha seleccionado a Stride Inc. (NYSE:LRN) como "Acción para Estudiar" para la edición de agosto de 2025, sugiriendo posibles oportunidades de inversión. El comité ofrecerá un análisis exhaustivo de los datos fundamentales de Stride, incluyendo ventas, ganancias, beneficio antes de impuestos y retorno sobre el capital. Además, la revista incluirá una revisión fundamental de Amgen Inc. (NASDAQ:AMGN), que el comité considera digna de estudio desde una perspectiva de infravaloración. El comité está formado por seis profesionales CFA, con Doron P. Levin como presidente.
BetterInvesting 매거진의 편집 자문 및 증권 검토 위원회는 2025년 8월호에서 Stride Inc. (NYSE:LRN)를 "연구할 주식"으로 선정하여 잠재적인 투자 기회를 제시했습니다. 위원회는 매출, 수익, 세전 이익, 자기자본 수익률 등 Stride의 기본 데이터를 종합적으로 분석할 예정입니다. 또한, 매거진은 Amgen Inc. (NASDAQ:AMGN)에 대한 기본적 검토도 다룰 예정이며, 위원회는 이를 저평가 관점에서 연구할 가치가 있다고 평가했습니다. 위원회는 6명의 CFA 전문가로 구성되며, Doron P. Levin이 위원장으로 활동하고 있습니다.
Le Comité consultatif éditorial et de révision des titres du magazine BetterInvesting a sélectionné Stride Inc. (NYSE:LRN) comme "Action à étudier" pour le numéro d'août 2025, suggérant des opportunités d'investissement potentielles. Le comité fournira une analyse complète des données fondamentales de Stride, incluant les ventes, les bénéfices, le bénéfice avant impôts et le rendement des capitaux propres. De plus, le magazine présentera une revue fondamentale de Amgen Inc. (NASDAQ:AMGN), que le comité considère comme digne d'étude sous un angle de sous-évaluation. Le comité est composé de six professionnels CFA, avec Doron P. Levin en tant que président.
Das Editorial Advisory und Securities Review Committee des BetterInvesting Magazins hat Stride Inc. (NYSE:LRN) als "Aktie zum Studium" für die August-Ausgabe 2025 ausgewählt und weist auf potenzielle Investitionsmöglichkeiten hin. Das Komitee wird eine umfassende Analyse der Fundamentaldaten von Stride liefern, einschließlich Umsatz, Gewinn, Gewinn vor Steuern und Eigenkapitalrendite. Zudem wird das Magazin eine fundamentale Überprüfung von Amgen Inc. (NASDAQ:AMGN) präsentieren, die das Komitee aus einer unterbewerteten Perspektive für lohnenswert hält. Das Komitee besteht aus sechs CFA-Experten, mit Doron P. Levin als Vorsitzendem.
Positive
  • None.
Negative
  • None.

TROY, Mich., May 27, 2025 /PRNewswire/ -- Stride Inc.'s recent report has investors wondering if the company's stock is overvalued. Or is it in the buy range? As such, the Editorial Advisory and Securities Review Committee of BetterInvesting Magazine considers Stride Inc. (NYSE:LRN) as worthy of further study and has named the company its "Stock to Study" for the August 2025 issue for investors' informational and educational use.

The fundamental data is eye-opening; investors can view Stride's sales, earnings, pre-tax profit, return on equity, and more all on one page, courtesy of the National Association of Investors Corp., here. 

A full report on Stride will appear in the August 2025 issue of BetterInvesting Magazine. 

The same issue of BetterInvesting Magazine will also include a fundamental review of Amgen Inc. (NASDAQ:AMGN), which the independent Editorial Advisory and Securities Review Committee believes is worthy of further study from an undervalued perspective. 

Committee members are Daniel J. Boyle, CFA; Marisa Bradbury, CFA; Philip Keating, CFA; Walter J. Kirchberger, CFA; Anne Nichols, CFA; and Dan Rutter, CFA.

Doron P. Levin, an editor of the magazine, serves as the committee's chairperson.

Securities mentioned are for study and presented for educational purposes only. They are not to be considered as endorsed or recommended for purchase by NAIC/BetterInvesting. Investors should conduct their own review and analysis of any company of interest using the Stock Selection Guide before making an investment decision.

About BetterInvesting:

BetterInvesting™, a national 501(c)(3) nonprofit, investment education organization, has been empowering everyday Americans since 1951. Also known as the National Association of Investors™ (NAIC®), we have helped more than 5 million people from all walks of life learn how to improve their financial future. BetterInvesting provides unbiased, in-depth investing education and powerful online stock analysis tools to create successful lifelong investors. BetterInvesting staff, along with a dedicated community of volunteers across America, teach the organization's principles and time-tested methodology to individuals and investment clubs. For more information about BetterInvesting, please visit www.betterinvesting.org

Follow us on LinkedIn, Instagram and Facebook.

Contact: 877-275-6242

Cision View original content:https://www.prnewswire.com/news-releases/betterinvesting-magazine-update-on-stride-inc-nyse-lrn-and-amgen-inc-nasdaq-amgn-302466516.html

SOURCE NAIC-BetterInvesting

FAQ

What is BetterInvesting Magazine's Stock to Study for August 2025?

BetterInvesting Magazine has selected Stride Inc. (NYSE:LRN) as its Stock to Study for the August 2025 issue.

Why is Amgen (NASDAQ:AMGN) being featured in BetterInvesting Magazine's August 2025 issue?

Amgen is being featured because the Editorial Advisory and Securities Review Committee believes it is worthy of further study from an undervalued perspective.

Who are the members of BetterInvesting Magazine's Editorial Advisory Committee?

The committee members are Daniel J. Boyle, CFA; Marisa Bradbury, CFA; Philip Keating, CFA; Walter J. Kirchberger, CFA; Anne Nichols, CFA; and Dan Rutter, CFA, with Doron P. Levin serving as chairperson.

What fundamental data will be analyzed for Stride Inc. (LRN) in the BetterInvesting Magazine report?

The report will analyze Stride's sales, earnings, pre-tax profit, return on equity, and other fundamental data.
Stock AMGN logo
Amgen Inc

NASDAQ:AMGN

AMGN Rankings

#86 Ranked by Market Cap
#1017 Ranked by Dividends

AMGN Latest News

May 16, 2025
AMGEN TO PRESENT AT THE 2025 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE
May 9, 2025
AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE
May 1, 2025
AMGEN REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS
Apr 28, 2025
AMGEN ANNOUNCES WEBCAST OF 2025 FIRST QUARTER FINANCIAL RESULTS
Apr 25, 2025
AMGEN ANNOUNCES $900 MILLION MANUFACTURING EXPANSION, CREATION OF 350 NEW JOBS IN OHIO

AMGN Stock Data

147.87B
536.42M
0.22%
82.06%
3.01%
Drug Manufacturers - General
Biological Products, (no Disgnostic Substances)
Link
United States
THOUSAND OAKS